Description
Acute cerebral toxicity during concurrent anti-HER2 therapy and radiotherapy for breast cancer brain metastases
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: Acute cerebral toxicity during concurrent anti-HER2 therapy and radiotherapy for breast cancer brain metastases
€2.42
